Evidence map›Paper›PMID 29167824›Full record

ArticleNPJ precision oncology2017

Protein activation mapping of human sun-protected epidermis after an acute dose of erythemic solar simulated light.

Janine G Einspahr, Clara Curiel-Lewandrowski, Valerie S Calvert, Steven P Stratton, David S Alberts, James Warneke, Chengcheng Hu, Kathylynn Saboda, Elisabeth L Wagener, Sally Dickinson and 3 more

Open access · goldAbstract read
In one paragraph

Article in NPJ precision oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Janine G EinspahrThe University of Arizona Cancer Center, 1515 North Campbell Ave., PO Box 245024, Tucson, AZ, USA.
Clara Curiel-LewandrowskiThe University of Arizona Cancer Center, 1515 North Campbell Ave., PO Box 245024, Tucson, AZ, USA.
Valerie S CalvertCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.
Steven P StrattonThe University of Arizona Cancer Center, 1515 North Campbell Ave., PO Box 245024, Tucson, AZ, USA.
David S AlbertsThe University of Arizona Cancer Center, 1515 North Campbell Ave., PO Box 245024, Tucson, AZ, USA.
James WarnekeThe University of Arizona Cancer Center, 1515 North Campbell Ave., PO Box 245024, Tucson, AZ, USA.
Chengcheng HuDepartment of Epidemiology and Biostatistics, The University of Arizona, Tucson, AZ, USA.
Kathylynn SabodaThe University of Arizona Cancer Center, 1515 North Campbell Ave., PO Box 245024, Tucson, AZ, USA.
Elisabeth L WagenerThe University of Arizona Cancer Center, 1515 North Campbell Ave., PO Box 245024, Tucson, AZ, USA.
Sally DickinsonThe University of Arizona Cancer Center, 1515 North Campbell Ave., PO Box 245024, Tucson, AZ, USA.
Zigang DongDepartment of Molecular Medicine and Biopharmaceutical Sciences, The Hormel Institute, The University of Minnesota, Austin, MN, USA.
Ann M BodeDepartment of Molecular Medicine and Biopharmaceutical Sciences, The Hormel Institute, The University of Minnesota, Austin, MN, USA.
Emanuel F PetricoinIIICenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, USA.
University of Arizona · USUniversity of Arizona Cancer CenterGeorge Mason University · USHormel (United States) · USUniversity of Minnesota · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
VITAMIN A, AND ITS PRECURSORS AND DERIVATIVES AS THERAPEUTIC MODALITIESP01CA027502 · NCI · UNIVERSITY OF ARIZONA · PI STRATTON, STEVEN P · 1985 to 2015
$36.3M
Prevention of UVB-induced skin cancer using sulforaphane: roles of AP-1 and Nrf2.K07CA132956 · NCI · UNIVERSITY OF ARIZONA · PI DICKINSON, SALLY E · 2008 to 2012
$671k
NCI NIH HHS K07 CA132956NCI NIH HHS P01 CA027502NCI NIH HHS P30 CA023074
6 · The paper itself

Abstract

Ultraviolet radiation is an important etiologic factor in skin cancer and a better understanding of how solar stimulated light (SSL) affects signal transduction pathways in human skin which is needed in further understanding activated networks that could be targeted for skin cancer prevention. We utilized Reverse Phase Protein Microarray Analysis (RPPA), a powerful technology that allows for broad-scale and quantitative measurement of the activation/phosphorylation state of hundreds of key signaling proteins and protein pathways in sun-protected skin after an acute dose of two minimal erythema dose (MED) of SSL. RPPA analysis was used to map the altered cell signaling networks resulting from acute doses of solar simulated radiation (SSL). To that end, we exposed sun-protected skin in volunteers to acute doses of two MED of SSL and collected biopsies pre-SSL and post-SSL irradiation. Frozen biopsies were subjected to laser capture microdissection (LCM) and then assessed by RPPA. The activation/phosphorylation or total levels of 128 key signaling proteins and drug targets were selected for statistical analysis. Coordinate network-based analysis was performed on specific signaling pathways that included the PI3k/Akt/mTOR and Ras/Raf/MEK/ERK pathways. Overall, we found early and sustained activation of the PI3K-AKT-mTOR and MAPK pathways. Cell death and apoptosis-related proteins were activated at 5 and 24 h. Ultimately, expression profile patterns of phosphorylated proteins in the epidermal growth factor receptor (EGFR), AKT, mTOR, and other relevant pathways may be used to determine pharmacodynamic activity of new and selective topical chemoprevention agents administered in a test area exposed to SSL to determine drug-induced attenuation or reversal of skin carcinogenesis pathways.

Identifiers

PMID29167824
PMCPMC5695572
OpenAlexW2756365722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.